Shield Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11.62	6.52	13.95	3.4	16.41
Cash & Short-Term Investments	11.62	6.52	13.95	3.4	16.41
Cash Growth	78.13%	-53.23%	309.99%	-79.27%	308.75%
Accounts Receivable	24.28	12.28	9.99	3.39	1.1
Other Receivables	0.11	10.54	1.23	1.13	1.3
Receivables	24.38	22.81	11.21	4.52	2.4
Inventory	9.21	5.66	3.2	1.76	2.21
Prepaid Expenses	-	2.44	2.9	2.5	2.35
Restricted Cash	-	0.5	-	-	-
Total Current Assets	45.22	37.94	31.26	12.17	23.37
Property, Plant & Equipment	0.11	0.37	0.67	0.24	0.41
Other Intangible Assets	18.89	1.05	1.18	1.23	23.46
Long-Term Deferred Charges	-	17.12	15.68	12.98	12.9
Other Long-Term Assets	1	1	-	-	-
Total Assets	65.22	57.48	48.8	26.62	60.14
Accounts Payable	37.43	6.52	4.05	1.74	1.78
Accrued Expenses	-	16.67	8.67	9.71	2.9
Current Portion of Leases	-	0.2	0.21	0.11	0.21
Current Income Taxes Payable	-	0.05	0.1	0.27	0.07
Other Current Liabilities	12.73	9.19	0.7	1.01	0.08
Total Current Liabilities	50.16	32.62	13.74	12.83	5.04
Long-Term Debt	30.14	26.17	19.84	6.68	-
Long-Term Leases	-	-	0.2	-	-
Other Long-Term Liabilities	-	-	-	0.56	-
Total Liabilities	80.29	58.8	33.77	20.07	5.04
Common Stock	20.44	19.91	15.01	5.37	4.38
Additional Paid-In Capital	204.61	203.19	198.76	169.48	155.15
Retained Earnings	-276.71	-259.85	-233.53	-201.11	-144.8
Comprehensive Income & Other	36.59	35.43	34.79	32.8	40.36
Shareholders' Equity	-15.08	-1.32	15.03	6.54	55.1
Total Liabilities & Equity	65.22	57.48	48.8	26.62	60.14
Total Debt	30.14	26.37	20.25	6.79	0.21
Net Cash (Debt)	-18.51	-19.85	-6.3	-3.39	16.2
Net Cash Growth	-	-	-	-	307.37%
Net Cash Per Share	-0.02	-0.03	-0.01	-0.01	0.08
Filing Date Shares Outstanding	723.81	1,042	782.06	259.39	215.89
Total Common Shares Outstanding	723.81	1,042	782.06	259.39	215.89
Working Capital	-4.94	5.32	17.53	-0.66	18.33
Book Value Per Share	-0.02	-0.00	0.02	0.03	0.26
Tangible Book Value	-33.96	-2.36	13.85	5.31	31.64
Tangible Book Value Per Share	-0.05	-0.00	0.02	0.02	0.15
Machinery	-	0.51	0.48	0.24	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.